Li QH - Search Results

1

Regimen containing perarubicin for the treatment of newly diagnosed young patients with acute myeloid leukemia.

Zhong LY, Li QH, Huang ZL, Lin W, Lu ZS, Weng JY, Wu SJ, Du X. Zhong LY, et al. Among authors: li qh. Ai Zheng. 2009 Jun;28(6):619-25. Ai Zheng. 2009. PMID: 19635200 Free article. Clinical Trial.

2

[Effects of combination therapy with all-trans retinoic acid and arsenic trioxide on acute promyelocytic leukemia].

Zhang GC, Zheng D, Li QH, Luo SK, Li J, Peng AH, Tong XZ, Tan EX, Hong WD. Zhang GC, et al. Among authors: li j, li qh. Ai Zheng. 2004 Apr;23(4):430-4. Ai Zheng. 2004. PMID: 15087033 Chinese.

3

[Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].

Zhang GC, Zheng D, Li QH, Li XH, Cai CC, Luo SK, Li J, Peng AH, Tong XZ, Tan EX, Hong WD. Zhang GC, et al. Among authors: li xh, li j, li qh. Ai Zheng. 2004 Dec;23(12):1696-9. Ai Zheng. 2004. PMID: 15601563 Chinese.

4

[Therapeutic effects of chemotherapeutic regimens containing pirarubicin on the treatment of high-risk or refractory and relapsed acute leukemia in adults].

Li QH, DU X, Huang ZL, Luo CW, Zhong LY, Lin W. Li QH, et al. Zhonghua Yi Xue Za Zhi. 2005 May 11;85(17):1195-7. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16029595 Chinese.

5

[Efficacy and safety of low-dose rasburicase for refractory chronic gouty arthritis].

Li QH, Mo YQ, Zeng WC, Tang AJ, Li HG, Chen LF, Wei XN, Liang JJ, Zheng DH, Dai L. Li QH, et al. Among authors: li hg. Zhonghua Yi Xue Za Zhi. 2023 Jun 6;103(21):1617-1622. doi: 10.3760/cma.j.cn112137-20221124-02496. Zhonghua Yi Xue Za Zhi. 2023. PMID: 37248061 Chinese.

6

[Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)].

Cui CH, Chang YN, Zhou J, Li CW, Wang HJ, Sun Q, Jia YJ, Li QH, Wang TY, Qiu LG, Yi SH. Cui CH, et al. Among authors: li cw, li qh. Zhonghua Xue Ye Xue Za Zhi. 2023 May 14;44(5):418-423. doi: 10.3760/cma.j.issn.0253-2727.2023.05.011. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 37550193 Free PMC article. Chinese.

7

[Mechanism of inflammatory microecological response to TAS2R14/SIgA/TSLP in regulating epithelial cell barrier in cold asthma rats through lung-gut axis by using Shegan Mahuang Decoction and bitter and purging Chinese herbs].

Yuan YM, Ye WD, Cheng Y, Li QH, Liu JX, Qiao JL, Wang K, Fang XM. Yuan YM, et al. Among authors: li qh. Zhongguo Zhong Yao Za Zhi. 2024 Dec;49(24):6713-6723. doi: 10.19540/j.cnki.cjcmm.20240722.403. Zhongguo Zhong Yao Za Zhi. 2024. PMID: 39805760 Chinese.

8

Specnuezhenide: Comprehensive review of pharmacology, pharmacokinetics and ethnomedicinal uses.

He GS, Xia JK, Li QH, Zheng Y, Shi CR, Li R, Hong Q, Chen XM. He GS, et al. Among authors: li qh. Fitoterapia. 2025 Jan 11;181:106389. doi: 10.1016/j.fitote.2025.106389. Online ahead of print. Fitoterapia. 2025. PMID: 39805507 Review.

9

Characterization of a new HIV-1 second-generation circulating recombinant form (CRF135_0107) and its next-generation recombinant in China.

Li QH, Zhang YQ, Li EL, Lu RR, Chen XH, Wang FX, Wang JY. Li QH, et al. J Infect. 2025 Jan;90(1):106382. doi: 10.1016/j.jinf.2024.106382. Epub 2024 Dec 24. J Infect. 2025. PMID: 39725236 Free article. No abstract available.

10

Different prevalence and spectrum of malignancy between Chinese patients and American patients with rheumatoid arthritis: a comparative study.

Ouyang ZM, Zou YW, Pan J, Lu Y, Yang Y, Li QH, Ma JD, Jia PW, Wu T, Fan YT, Lin JZ, Wei XN, Yang KM, Su Y, Dai L. Ouyang ZM, et al. Among authors: li qh. PeerJ. 2024 Dec 18;12:e18650. doi: 10.7717/peerj.18650. eCollection 2024. PeerJ. 2024. PMID: 39713142 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

660 results

Search Page

Filters